These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38581435)

  • 21. Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.
    Wang VM; Rosen RB; Meyerle CB; Kurup SK; Ardeljan D; Agron E; Tai K; Pomykala M; Chew EY; Chan CC; Tuo J
    Mol Vis; 2012; 18():2578-85. PubMed ID: 23112570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
    Inan S; Polat O; Karadas M; Inan UU
    Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
    [No Abstract]   [Full Text] [Related]  

  • 23. Intraocular Vascular Endothelial Growth Factor Levels in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.
    Hata M; Yamashiro K; Ooto S; Oishi A; Tamura H; Miyata M; Ueda-Arakawa N; Takahashi A; Tsujikawa A; Yoshimura N
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):292-298. PubMed ID: 28114590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aqueous Humor Cytokines and Long-Term Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema.
    Felfeli T; Juncal VR; Hillier RJ; Mak MYK; Wong DT; Berger AR; Kohly RP; Kertes PJ; Eng KT; Boyd SR; Altomare F; Giavedoni LR; Muni RH
    Am J Ophthalmol; 2019 Oct; 206():176-183. PubMed ID: 30959004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-VEGF-refractory exudative age-related macular degeneration: differential response according to features on optical coherence tomography.
    Shin JY; Woo SJ; Ahn J; Park KH
    Korean J Ophthalmol; 2013 Dec; 27(6):425-32. PubMed ID: 24311928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Aqueous Flare Levels Following Intravitreal Ranibizumab Injection for Neovascular Age-related Macular Degeneration.
    Uzun A; Yalcindag FN; Demirel S; Batýoðlu F; Ozmert E
    Ocul Immunol Inflamm; 2017 Apr; 25(2):229-232. PubMed ID: 26828124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Mechanistic Model of the Intravitreal Pharmacokinetics of Large Molecules and the Pharmacodynamic Suppression of Ocular Vascular Endothelial Growth Factor Levels by Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration.
    Hutton-Smith LA; Gaffney EA; Byrne HM; Maini PK; Schwab D; Mazer NA
    Mol Pharm; 2016 Sep; 13(9):2941-50. PubMed ID: 26726925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aqueous vascular endothelial growth factor and ranibizumab concentrations after monthly and bimonthly intravitreal injections of ranibizumab for age-related macular degeneration.
    Wang X; Sawada T; Kakinoki M; Miyake T; Kawamura H; Saishin Y; Liu P; Ohji M
    Graefes Arch Clin Exp Ophthalmol; 2014 Jul; 252(7):1033-9. PubMed ID: 24196779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration.
    Boltz A; Ruiß M; Jonas JB; Tao Y; Rensch F; Weger M; Garhöfer G; Frantal S; El-Shabrawi Y; Schmetterer L
    Ophthalmology; 2012 Aug; 119(8):1615-20. PubMed ID: 22521084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline characteristics and progression of neovascular age-related macular degeneration in patients receiving over 60 intravitreal injections of anti-vascular endothelial growth factor.
    Prahs P; Brandl C; Helbig H; Volz C
    Rom J Ophthalmol; 2023; 67(3):260-266. PubMed ID: 37876508
    [No Abstract]   [Full Text] [Related]  

  • 31. Factors Associated with Recurrence of Age-Related Macular Degeneration after Anti-Vascular Endothelial Growth Factor Treatment: A Retrospective Cohort Study.
    Kuroda Y; Yamashiro K; Miyake M; Yoshikawa M; Nakanishi H; Oishi A; Tamura H; Ooto S; Tsujikawa A; Yoshimura N
    Ophthalmology; 2015 Nov; 122(11):2303-10. PubMed ID: 26271842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Vascular Endothelial Growth Factor Intravitreal Therapy and Macular Ganglion Cell Layer Thickness in Patients with Neovascular Age-Related Macular Degeneration.
    Abdolrahimzadeh S; Gharbiya M; Formisano M; Bertini F; Cerini A; Pacella E
    Curr Eye Res; 2019 Sep; 44(9):1000-1005. PubMed ID: 30999772
    [No Abstract]   [Full Text] [Related]  

  • 33. Glaucoma Tube Outcomes with and without Anti-VEGF in Patients with Age-related Macular Degeneration.
    Rothman AL; Beca FA; Tijerina JD; Schuman DM; Parrish RK; Vanner EA; Liu KC
    Ophthalmol Glaucoma; 2024; 7(3):260-270. PubMed ID: 38266962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration.
    Invernizzi A; Nguyen V; Arnold J; Young S; Barthelmes D; Gillies MC
    Ophthalmology; 2018 Feb; 125(2):237-244. PubMed ID: 28993010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraocular and systemic inflammation-related cytokines during one year of ranibizumab treatment for neovascular age-related macular degeneration.
    Fauser S; Viebahn U; Muether PS
    Acta Ophthalmol; 2015 Dec; 93(8):734-8. PubMed ID: 26016605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study.
    Bontzos G; Bagheri S; Ioanidi L; Kim I; Datseris I; Gragoudas E; Kabanarou S; Miller J; Tsilimbaris M; Vavvas DG
    Ophthalmol Retina; 2020 Dec; 4(12):1138-1145. PubMed ID: 31937473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-VEGF response in macular hemorrhage and incidence of retinal pigment epithelial tears.
    Varshney N; Jain A; Chan V; Yu L; Sarraf D
    Can J Ophthalmol; 2013 Jun; 48(3):210-5. PubMed ID: 23769784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose Metabolic Characterization of Human Aqueous Humor in Relation to Wet Age-Related Macular Degeneration.
    Han G; Wei P; He M; Teng H
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):49. PubMed ID: 32232346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular Degeneration.
    Enseleit F; Michels S; Sudano I; Stahel M; Zweifel S; Schlager O; Becker M; Winnik S; Nägele M; Flammer AJ; Neidhart M; Graf N; Matter CM; Seifert B; Lüscher TF; Ruschitzka F
    Ophthalmologica; 2017; 238(4):205-216. PubMed ID: 28866675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the Ganglion Cell-inner Plexiform Layer after Consecutive Intravitreal Injections of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration Patients.
    Kim SY; Yoon MH; Chin HS
    Korean J Ophthalmol; 2020 Feb; 34(1):11-18. PubMed ID: 32037745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.